Ubras has raised “tens of millions of US dollars” in a Series B+ round led by Sequoia Capital China, while Beijing WeMed Medical Equipment has bagged 100 million yuan ($14 million) in a Series C+ round from Hillhouse Capital.
Continue reading this premium story with a subscription to DealStreetAsia.Subscribe
Already a Subscriber? Log in
Contact us for corporate subscriptions at firstname.lastname@example.org